⌘K

Home/Filings/4/0000899243-21-039959

4//SEC Filing

Bachleda Mark 4

Accession 0000899243-21-039959

CIK 0001563577other

View on SEC.gov Company Profile

Filed

Oct 11, 8:00 PM ET

Accepted

Oct 12, 8:23 PM ET

Size

5.4 KB

Accession

0000899243-21-039959

Insider Transaction Report

Form 4

Period: 2021-10-08

Galera Therapeutics, Inc.GRTX

Chief Commercial Officer

Transactions

Award
Stock Option (Right to Buy)
2021-10-08+200,000→ 200,000 total
Exercise: $7.84Exp: 2031-10-07→ Common Stock (200,000 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable as to 25% on October 8, 2022, and in thirty-six (36) substantially equal monthly installments over a three year period thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Galera Therapeutics, Inc.

CIK 0001563577

Entity typeother

Related Parties

1

filerCIK 0001887762

Filing Metadata

Form type: 4
Filed: Oct 11, 8:00 PM ET
Accepted: Oct 12, 8:23 PM ET
Size: 5.4 KB

View on SEC.gov